|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 10
Zeitschriftenartikel
Fowler, Nathan Hale; Dickinson, Michael; Dreyling, Martin; Martinez-Lopez, Joaquin; Kolstad, Arne; Butler, Jason; Ghosh, Monalisa; Popplewell, Leslie; Chavez, Julio C.; Bachy, Emmanuel; Kato, Koji; Harigae, Hideo; Kersten, Marie Jose; Andreadis, Charalambos; Riedell, Peter A.; Ho, P. Joy; Perez-Simon, Jose Antonio; Chen, Andy I.; Nastoupil, Loretta J.; Tresckow, Bastian von; Ferreri, Andres Jose Maria; Teshima, Takanori; Patten, Piers E. M.; McGuirk, Joseph P.; Petzer, Andreas L.; Offner, Fritz; Viardot, Andreas; Zinzani, Pier Luigi; Malladi, Ram; Zia, Aiesha; Awasthi, Rakesh; Masood, Aisha; Anak, Oezlem; Schuster, Stephen J. und Thieblemont, Catherine
(2021):
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial.
In: Nature Medicine, Bd. 28, Nr. 2: S. 325-332
Matasar, Matthew J.; Dreyling, Martin; Leppa, Sirpa; Santoro, Armando; Pedersen, Michael; Buvaylo, Viktoriya; Fletcher, Monique; Childs, Barrett H. und Zinzani, Pier Luigi
(2021):
Feasibility of Combining the Phosphatidylinositol 3-Kinase Inhibitor Copanlisib With Rituximab-Based Immunochemotherapy in Patients With Relapsed Indolent B-cell Lymphoma.
In: Clinical Lymphoma Myeloma & Leukemia, Bd. 21, Nr. 11, E886-E894
Panayiotidis, Panayiotis; Follows, George A.; Mollica, Luigina; Nagler, Arnon; Ozcan, Muhit; Santoro, Armando; Stevens, Don; Trevarthen, David; Hiemeyer, Florian; Garcia-Vargas, Jose; Childs, Barrett H.; Zinzani, Pier Luigi und Dreyling, Martin
(2021):
Efficacy and safety of copanlisib in patients with relapsed or refractory marginal zone lymphoma.
In: Blood Advances, Bd. 5, Nr. 3: S. 823-828
Dreyling, Martin; Santoro, Armando; Mollica, Luigina; Leppä, Sirpa; Follows, George; Lenz, Georg; Kim, Won Seog; Nagler, Arnon; Dimou, Maria; Demeter, Judit; Özcan, Muhit; Kosinova, Marina; Bouabdallah, Krimo; Morschhauser, Franck; Stevens, Don A.; Trevarthen, David; Munoz, Javier; Rodrigues, Liana; Hiemeyer, Florian; Miriyala, Ashok; Garcia‐Vargas, Jose; Childs, Barrett H. und Zinzani, Pier Luigi
(2020):
Long‐term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2‐year follow‐up of the CHRONOS‐1 study.
In: American Journal of Hematology, Bd. 95, Nr. 4: S. 362-371
[PDF, 1MB]
Zinzani, Pier Luigi; Flinn, Ian W.; Yuen, Sam L. S.; Topp, Max S.; Rusconi, Chiara; Fleury, Isabelle; Le Du, Katell; Arthur, Christopher; Pro, Barbara; Gritti, Giuseppe; Crump, Michael; Petrich, Adam; Samineni, Divya; Sinha, Arijit; Punnoose, Elizabeth A.; Szafer-Glusman, Edith; Spielewoy, Nathalie; Mobasher, Mehrdad; Humphrey, Kathryn; Kornacker, Martin und Hiddemann, Wolfgang
(2020):
Venetoclax-rituximab with or without bendamustine vs bendamustine-rituximab in relapsed/refractory follicular lymphoma.
In: Blood, Bd. 136, Nr. 23: S. 2628-2637
Zinzani, Pier Luigi; Dreyling, Martin; Gradishar, William; Andre, Marc; Esteva, Francisco J.; Boulos, Suliman; Barca, Eva Gonzalez und Curigliano, Giuseppe
(2019):
Are Biosimilars the Future of Oncology and Haematology?
In: Drugs, Bd. 79, Nr. 15: S. 1609-1624
Morschhauser, Franck; Flinn, Ian W.; Advani, Ranjana; Sehn, Laurie H.; Diefenbach, Catherine; Kolibaba, Kathryn; Press, Oliver W.; Salles, Gilles; Tilly, Herve; Chen, Andy I.; Assouline, Sarit; Cheson, Bruce D.; Dreyling, Martin; Hagenbeek, Anton; Zinzani, Pier Luigi; Jones, Surai; Cheng, Ji; Lu, Dan; Penuel, Elicia; Hirata, Jamie; Wenger, Michael; Chu, Yu-Waye und Sharman, Jeff
(2019):
Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS).
In: Lancet Haematology, Bd. 6, Nr. 5, E254-E265
Dreyling, Martin; Aurer, Igor; Cortelazzo, Sergio; Hermine, Olivier; Hess, Georg; Jerkeman, Mats; Le Gouill, Steven; Ribrag, Vincent; Trneny, Marek; Visco, Carlo; Walewski, Jan; Zaja, Francesco und Zinzani, Pier Luigi
(2018):
Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendations.
In: Leukemia & Lymphoma, Bd. 59, Nr. 8: S. 1814-1828
Dreyling, Martin; Santoro, Armando; Mollica, Luigina; Leppä, Sirpa; Follows, George A.; Lenz, Georg; Kim, Won Seog; Nagler, Arnon; Panayiotidis, Panayiotis; Demeter, Judit; Özcan, Muhit; Kosinova, Marina; Bouabdallah, Krimo; Morschhauser, Franck; Stevens, Don A.; Trevarthen, David; Giurescu, Marius; Cupit, Lisa; Liu, Li; Köchert, Karl; Seidel, Henrik; Pena, Carol; Yin, Shuxin; Hiemeyer, Florian; Garcia-Vargas, Jose; Childs, Barrett H. und Zinzani, Pier Luigi
(2017):
Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma.
In: Journal of Clinical Oncology, Bd. 35, Nr. 35: S. 3898-3910
Cheson, Bruce D.; Brugger, Wolfram; Damaj, Gandhi; Dreyling, Martin; Kahl, Brad; Kimby, Eva; Ogura, Michinori; Weidmann, Eckhart; Wendtner, Clemens-Martin und Zinzani, Pier Luigi
(2016):
Optimal use of bendamustine in hematologic disorders: Treatment recommendations from an international consensus panel - an update.
In: Leukemia & Lymphoma, Bd. 57, Nr. 4: S. 766-782